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Objective:Bronchopleural fistula is a severe complication after pneumonectomy or lobectomy. Local application
of silver nitrate to seal bronchopleural fistulae was reported once 25 years ago with considerable success but was
never repeated.We aimed to develop and evaluate a concrete technique of applying silver nitrate through a flexible
bronchoscope to treat bronchopleural fistulae in central airways.
Methods:Consecutive patients with small (5mm) bronchopleural fistulae in proximal airways were included in
the study. After measurement of bronchopleural fistula size through a flexible videobronchoscopy, a standard
bronchoscopic cytology brush covered with silver nitrate was passed through the working channel of the scope
and was rubbed against the fistula’s orifice producing blanching and edema on the mucosa. This procedure was
repeated until closure of the fistula’s orifice (treatment success) or absence of any tissue response after 2 broncho-
scopic sessions (treatment failure).
Results: Of 16 patients referred, 5 were excluded from treatment because of large (>5 mm) fistulae. Among the
11 treated patients (median fistula diameter 3 mm, range 2–5 mm), treatment failure was observed in 2 patients in
whom treatment was attempted early (15 days postsurgery). In the remaining 9 patients, treatment success was
achieved (81.8% success rate) after a median of 2.5 (range 1–10) applications of silver nitrate. After 11 (0.5–24)
months of follow-up, no relapse was observed among successfully treated fistulae.
Conclusion: The local application of silver nitrate through a flexible bronchoscopic brush produced a burn and
healing process on the mucosa of small bronchopleural fistulae of the central airways, leading to effective and
lasting treatment in most cases.
Stratakos et al General Thoracic SurgeryBronchopleural fistula (BPF), defined as communication be-
tween the bronchial tree and the pleural space, is a severe
complication after pneumonectomy or lobectomy. It is asso-
ciated with serious mortality ranging from 25% to 67% in
various studies, with disabling morbidity occurring even
more often.1,2 The incidence of this complication, although
decreased in past decades after better understanding of the
bronchial healing process, refinements of surgical tech-
niques, and advances in postoperative intensive care, has
been recently reported at 4.5% to 20% after pneumonec-
tomy and 0.5% after lobectomy.1-5
Even small fistulae can produce immediate devastating
sequelae, namely, chronic purulent infection, empyema,
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mechanical ventilation.6
Successful BPF treatment requires aggressive control of
infection, adequate drainage of the chest cavity, closure of
the fistula, and obliteration of the pleural space.4 Scientific
evidence for the management of BPF is scarce and based
mainly on experts’ opinion or case reports.5-9 Therapeutic
options range from extensive surgical procedures, including
transsternal mediastinal closure of the BPF (Abruzzini tech-
nique), repetition of thoracotomy, thoracoplasty, or chest
wall fenestration, to several more conservative bronchoscopic
techniques attempting to seal abnormal communication.5,6
Surgical maneuvers include debridement and closure with
buttressing of a pedicled omental or muscle flap. The thera-
peutic strategy is dependent on the clinical, oncologic, and
nutritional status of the patient and the size of the fistula,
but the tendency in the decision making process is, if feasible,
toward a less interventional approach. For that reason, there
are a variety of sophisticated alternatives that have been
reported in the recent surgical and interventional literature.
In a recent meta-analysis7 of 85 post-pneumonectomy
BPFs reported in the literature as treated endoscopically,
the question was addressed whether the bronchoscopic ap-
proach was effective compared with a conventional rethora-
cotomy. There was 40% mortality and a 30% cure rateardiovascular Surgery c Volume 138, Number 3 603
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BPF ¼ bronchopleural fistula
using a wide range of bronchoscopic procedures that were
broadly categorized as (a) tracheobronchial stenting,8 (b) oc-
clusion with glue or other chemical or biological seal-
ants,9,10 and (c) procedures to induce scar tissue
formation.11-14 The latter category, mainly referring to neo-
dymium-doped yttrium aluminium garnet laser applica-
tion,11 submucosal injections of the vein sclerosant
polidocanol,12 and submucosal alcohol injections,13 has
shown promising results with resolution of small (<3 mm)
BPFs in central airways in a proportion ranging from 33%
to 58%with relatively few complications and lowmortality.
In 1984, a Danish group published their experience on
successful closing of at least 10 BPFs by repeated applica-
tion of silver nitrate using the rigid bronchoscope combined
with effective surgical drainage when necessary.14 Silver ni-
trate application produced burn-related scar formation and
granulation that was able to occlude fistulae in the majority
of their cases. Since then, although the applied technique
was only vaguely described, this process has been quoted
and cited in all reviews on the subject but was never repeated
by either rigid or flexible bronchoscopy.5-7
Facing such a severe surgical complication for which
a gold standard established treatment of choice is missing,
and taking into account the promising results of the sole re-
port on silver nitrate use with rigid bronchoscopy,14 we
aimed to investigate the value of silver nitrate when applied
on BPFs with flexible bronchoscopy. More specifically, we
aimed to develop and evaluate a concrete and practical tech-
nique of applying silver nitrate on the bronchial mucosa
through a flexible videobronchoscope intending to treat
small (5 mm) BPFs in central airways. We also aimed to
prospectively evaluate the effectiveness and safety of such
a technique on long-term follow-up. We hypothesized that
repeated use of this technique would result in effective and
safe closure of small (5 mm at maximum diameter)
BPFs in proximal airways.
PATIENTS AND METHODS
Approval from the ethical committee of our institutions was obtained to
study the bronchoscopic application of silver nitrate with the purpose of
treating small proximal BPF.
Study Group
All consecutive patients with post-pneumonectomy or post-lobectomy
BPFs, referred after interdisciplinary counseling to the Critical Care and
Respiratory Division of Athens University (Greece) and to the Pulmonary
Diseases Unit of Ancona Hospital (Italy) for endoscopic treatment, were
eligible for the study. Exclusion criteria were peripheral location (beyond
bronchoscopic reach) or large size of the fistula (>5 mm). In all patients
in whom hydropneumothorax was evident on chest x-ray, the pleural drain-604 The Journal of Thoracic and Cardiovascular Surage tube was placed at the affected side before bronchoscopic evaluation.
All patients gave written informed consent.
Procedure
Patients underwent flexible videobronchoscopy under conscious seda-
tion (midazolam, 2.5mg) to visualize and measure the abnormal communi-
cation. BPF size of 5 mm or less was estimated with a standard
bronchoscopic biopsy forceps measuring 5 mm at its full opening. The first
attempt to treat BPF with application of silver nitrate was undertaken during
the initial diagnostic bronchoscopy.
A standard bronchoscopic cytology brush was especially prepared to act
as a silver nitrate applicator. Conventional silver nitrate rods melt and di-
rectly turn to a liquid phase when exposed to flame. Drops of melted silver
nitrate material were allowed to evenly cover a standard cytology broncho-
scopic brush and solidify. This process was done repeatedly until the entire
surface of the brush was covered with silver nitrate, taking care not to in-
crease its diameter excessively, which would impede the brush from passing
through the 3.2-mm caliber working channel of an interventional video-
bronchoscope (Olympus BF-XT160, Olympus America Inc, Melville,
NY). This preparation was undertaken by a nurse in an adequately aerated
room under aspiration to avoid inspiration of harmful vapors of silver
nitrate.
The bronchoscope was then positioned as close as possible to the orifice
of the fistula, and with continuous aspiration the mucosa was dried of secre-
tions. Then, the silver nitrate applicator was passed through the working
channel of the bronchoscope and was gently rubbed against the mucosal
borders of the fistula. If excessive force was exerted at this point, a piece
FIGURE 1. A, Small (3 mm) BPF of the left main bronchus, approxi-
mately 0.5 cm lower than the main carina (case 1). B, After application of
silver nitrate, burn of the bronchial mucosa is manifested with a characteris-
tic blanching effect of the mucosal surface and scar formation resulting in
complete occlusion of the abnormal communication.gery c September 2009
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Patient
No.
Age
(y) Gender
Surgical
treatment
Bronchopleural fistulae
Location
Size
(mm)
Time from
surgery
(mo)
Complications;
symptoms
Bronchoscopy
sessions (n)
Outcome of
treatment
Follow up
(mo); cause
of death
1 53 Male Right PNY for
NSCLC
LMB adjacent
to the stump
3 12 Empyema; fever,
cough, purulent
expectoration
1 Definitive
closure
16; pulmonary
embolism
2 71 Male Left upper
LBY for
actinomycoma
Stump 2 84 Empyema; fever,
cough, purulent
expectoration
2 Definitive
closure
10
3 57 Male Left PNY for
NSCLC
Stump 3 6 Pyo-pneumothorax;
cough
1 Definitive
closure
8
4 65 Male Left PNY for
mesothelioma
Stump 5 3 Purulent
expectoration
10 Definitive
closure
12
5 72 Male Right PNY for
NSCLC
Stump 3 2 Purulent
expectoration
6 Definitive
closure
16
6 68 Male Right PNY for
NSCLC
Stump 4 0.5 Fever and
productive
cough
1 Failure —
7 74 Male Right upper LBY
for NSCLC
Stump 3 0.5 Empyema; fever 1 Failure —
NSCLC, Non–small cell lung cancer; PNY, pneumonectomy; LBY, lobectomy; LMB, left main bronchus.of the silver nitrate material on the brush could be detached and dropped
freely on the stump mucosal surface, requiring immediate removal by aspi-
ration or forceps. After 5 seconds of contact of the brush with the bronchial
mucosa, the applicator was retracted and bronchoscopists could inspect the
bronchial wall. Applications were continued in a circumferential way in 5-
second sessions until blanching and edema of the mucosa appeared all
around the fistula’s orifice as evidence of burn damage on the bronchial
wall (Figure 1).
Monitor and Follow-up
Bronchoscopy was repeated 2 to 3 days later to inspect the early cicatri-
cial effect of the silver nitrate application and to evaluate sealing of the ab-
normal communication. If effective sealing was not accomplished, the
procedure was repeated up to 10 times at intervals of 5 to 7 days. When ef-
fective sealing was achieved (treatment success), the patient was discharged
and reexamined bronchoscopically in 1 month and 6 months’ time for fol-
low-up. Treatment failure was defined as absence of any tissue response (ie,
blanching and edema of the mucosa) or increase of the size of the fistula after
2 therapeutic bronchoscopic sessions. In such cases, no further attempt to
use this approach was undertaken.
RESULTS
Between January 1, 2006, and December 31, 2007, 16 pa-
tients with post-pneumonectomy or post-lobectomy BPFs
were referred to the interventional pulmonology department
of our institutions for endoscopic management instead of
surgical approach. Five of them were excluded: One patient
had a surgical complication (the presence of a cartilage piece
in the suture line of the stump), and 4 patients had large (>5
mm) fistula orifices.
Eleven patients were enrolled in the study (Table 1). All
were male, with a median age of 69.5 years (range, 48–78
years). Seven patients had undergone pneumonectomy andThe Journal of Thoracic and4 patients had undergone lobectomy for malignant (9 pa-
tients, 7 with non–small cell lung cancer and 2 with meso-
thelioma) and nonmalignant (2 patients, 1 with abscessed
mycetoma caused by Actinomyces israeli and 1 with bron-
chiectasis) diseases. Surgical margins in patients with ma-
lignant disease were proven negative at the time of
surgery.
The median diameter of the BPF orifice was 3 mm (range
2–5mm), and the time from surgical intervention to diagnosis
was 3 (0.5–84) months. The treatment procedure required 2.5
(1–10) bronchoscopic sessionswith silver nitrate applications
and resulted in definite BPF closure in 9 patients (81.8%;
treatment success) and BPF closure failure in 2 patients
(18.18%; treatment failure). More specifically, patients 1
and 3 required only 1 session of silver nitrate application be-
cause in subsequent bronchoscopies complete cicatricial
healing of the fistula with granulation tissue formation was
evident (Figure 1). Patients 2, 4, 5, and 8 to 11 required re-
peated applications of silver nitrate (2–10) until complete
closure of the fistula orifice and healing were observed
(Figure 2). Patients 6 and 7 were treated early (15 days) post-
surgery. Bronchoscopic application of silver nitrate in these 2
patients failed to produce healing and closure of the fistula.
The application increased the size of the fistula’s orifice and
led to deterioration of the patients’ condition. Two patients
were referred back to thoracic surgeons for surgical treatment.
After a median follow-up of 11 months (range, 0.5–24
months), no relapse occurred in the 9 successfully treated
patients. Two of these patients died of reasons unrelated to
BPF 0.5 and 16 months after bronchoscopic treatment.Cardiovascular Surgery c Volume 138, Number 3 605
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In patients undergoing resection for lung cancer, risk fac-
tors for BPFs include locally advanced cases, residual tumor
on the stump, right lung or right lower lobe resection, peri-
operative fever, steroid use, presence of microbial infection,
large diameter (>25 mm) of the bronchial stump, and con-
current radiation therapy or chemotherapy.2,5 BPFs occur-
ring within 1 week of surgery are classified as acute forms
and are not necessarily associated with empyema, whereas
the subacute or chronic forms are usually associated with
bacterial infection of the lung and pleural space. Mortality
FIGURE 2. A, Dehiscence of the left main bronchus stump producing BPF
and pyopneumothorax is observed (case 3). B, Immediate scar formation
after application of silver nitrate leads to direct elimination of air leak. C,
Complete, uneventful healing of the stump is evident 1 month later.606 The Journal of Thoracic and Cardiovascular Suranges from 25% to 67%, the most common cause of death
being aspiration pneumonia with subsequent acute respira-
tory distress syndrome.3,5
Sirbu and colleagues2 recently published a large series of
490 lung resections for non–small cell lung cancer reporting
a 4.4% overall incidence of BPF, recognizing right pneumo-
nectomy as the main risk factor for the higher incidence
(13.5%) of this complication. In our series, 7 of 11 patients
had right-sided BPF, and 7 of 11 patients had undergone
pneumonectomy (Table 1).
Cooper and Miller15 recently recommended a stepwise
management of patients with BPF. Emergency drainage
and proper antimicrobial coverage are required when pneu-
mothorax and empyema are present. Bronchoscopic evalua-
tion of the airways is warranted in all cases. When large
major bronchus stump dehiscence is evident, immediate re-
suture and reinforcement are necessary. Many patients may
require consecutive operations and various accesses to
achieve a successful result. In the series of Puskas and col-
leagues,16 the patients had already undergone an average
of 3.3 surgical procedures to correct their BPF during
a mean interval of 24 months before the treatment applied
by the authors. Aggressive surgical options, such as open
window drainage or thoracoplasty, are often problematic
for an already compromised patient. Endoscopic fistula clo-
sure is an attractive alternative to avoid major surgical inter-
ventions.6 However, this procedure needs evaluation of the
prerequisites for its application, under which circumstances,
to whom, and when.
Several studies have reported on the implantation of dif-
ferent materials in the bronchus through a bronchoscope in
an attempt to stop the air leak. Materials used have included
Gelfoam, doxycycline, blood, fibrin glue, vascular occlusion
coils, endobronchial valves, tissue glues, sclerosing agents,
human spongiosa, gelatin-sponge particles, lead plugs, bal-
loons, absolute ethanol, or laser beam inducing scar forma-
tion.5 West and colleagues,7 in a recently published best
evidence topic, identified 85 cases of post-pneumonectomy
BPFs reported in the literature to have undergone broncho-
scopic procedures to attempt repair, with an approximate
cure rate of 35% for BPFs 5 mm or less. In the light of these
data, our finding of an 82% successful treatment rate for
BPFs 5 mm or less is encouraging. Silver salts have antisep-
tic and cauterizing properties and have recently been used
successfully for pleurodesis in humans.17,18 Application of
silver nitrate causes tissue burn and local inflammation
followed by normal healing process and scar formation.
Høier-Madsen and colleagues14 applied silver nitrate to 10
patients with BPF after pneumonectomy for non–small
cell lung cancer through the rigid bronchoscope. The appli-
cation of silver nitrate destroyed the epithelium in the bron-
chial stump and induced granulation, achieving the closure
of the fistula in all surviving patients. However, no details
were given on the exact technique used, and completergery c September 2009
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reported.
In our study, the results of local application of this caustic
material with the described technique on the mucosa of the
BPF orifice were encouraging. All patients were treated by
flexible videobronchoscope under only conscious sedation,
thus avoiding major interventions and general anesthesia.
In most treated patients, effective and uneventful closure
of the fistula was accomplished, resulting in dramatic im-
provement of clinical status. Two cases in which failure to
seal the fistulae was noted were subacute forms of BPF in
which we intervened within 15 days after surgery. It is likely
that this early intervention resulted in the inability to produce
cicatricial tissue to seal the communication. It is probable
that treatment should be better attempted at least 1 month af-
ter surgery when the scar tissue is well organized and the
possibility to induce further healing and granulation is
higher.
Study Limitations
The small number of patients with BPFs recruited for
bronchoscopic treatment is a study limitation. It should be
noted, however, that the small number of patients is partly
the result of restricted inclusion and exclusion criteria,
mainly the criterion mandating treatment trial in BPFs of
small size (5 mm). This criterion was included because
BPFs of this size have a higher possibility of cure by bron-
choscopic techniques according to previously published
experience.3-6
Another limitation is the absence of a control group of
patients with BPFs of similar size treated with another bron-
choscopic technique or even with surgical procedures. This
limitation is, however, inherent to the small number of
patients included, making the design of a control study
impossible.
Another possible limitation is the number of broncho-
scopic applications of silver nitrate required to attain healing
of the fistula. In most cases in our series, several applications
have been used (2–10) until complete and definitive closure
of the fistula was achieved. The need for repeated broncho-
scopic treatment can hardly be foreseen and is mainly based
on subjective evaluation of the attained results by the endo-
scopist. However, no complications or other sequelae have
been noted because of the repeated bronchoscopic treatment
sessions. The risk of detachment of caustic material from the
applicator brush is real and warrants extra caution and skill
by the endoscopist to prevent and manage.
It is possible that wider use of the method will generate
initiatives from the industry to manufacture and produce
specialized applicators of silver nitrate, which would hope-
fully render this technique safer and even more efficacious.The Journal of Thoracic andAn obvious advantage of flexible bronchoscope use com-
pared with rigid bronchoscope use is the higher accessibility
for patients not fit for general anesthesia and for physicians
not accustomed to the use of the rigid scope.
CONCLUSIONS
Our study describes a technique using a flexible broncho-
scopic brush and silver nitrate application for the treatment
of small (5 mm maximal diameter) BPFs. A high closure
rate (>80%) was observed in our small patient population.
Nevertheless, the ultimate place of bronchoscopic approach
in the management of BPFs, and particularly the contribu-
tion of our series using silver nitrate application, cannot be
determined yet. Further investigation of this technique in
larger series is warranted before this question is clearly
answered.
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